Federal Register/Vol. 84, No. 21/Thursday, January 31, 2019

Total Page:16

File Type:pdf, Size:1020Kb

Federal Register/Vol. 84, No. 21/Thursday, January 31, 2019 578 Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Proposed Rules ADAMS accession No./ Document Federal Register citation ‘‘40 CFR Part 192, Health and Environmental Protection Standards for Uranium and Thorium Mill Tailings; Proposed Rule,’’ 82 FR 7400 January 19, 2017. ‘‘40 CFR Part 192, Health and Environmental Protection Standards for Uranium and Thorium Mill Tailings; Proposed Rule; 83 FR 54543 Withdrawal,’’ October 30, 2018. NUREG–1569, ‘‘Standard Review Plan for In Situ Leach Uranium Extraction License Applications: Final Report,’’ June 2003 ML032310005 ‘‘NRC Staff’s Comments on EPA Proposed Rulemaking for 40 CFR Part 192 Rule, 82 FR 7400,’’ July 17, 2017 ..................... ML17173A638 ‘‘40 CFR Part 192, Environmental Standards for Uranium and Thorium Mill Tailings at Licensed Commercial Processing 48 FR 45926 Sites; Final Rule,’’ October 7, 1983. ‘‘40 CFR Part 192, Environmental Standards for Uranium and Thorium Mill Tailings at Licensed Commercial Processing 58 FR 60340 Sites; Final Rule,’’ November 15, 1993. ‘‘Uranium Mill Tailings Regulations; Conforming NRC Requirements to EPA Standards; Final Rule,’’ October 16, 1985 .......... 50 FR 41852 ‘‘40 CFR Part 192, Health and Environmental Protection Standards for Uranium and Thorium Mill Tailings; Proposed Rule,’’ 80 FR 4156 January 26, 2015. Throughout the development of this recover approximately 90 percent of its Washington, DC 20555–0001, ATTN: assessment, the NRC may post related annual budget through fees less certain Rulemakings and Adjudications Staff. documents, including public comments, amounts excluded from this fee- • Hand deliver comments to: 11555 on the Federal rulemaking website at recovery requirement. President Trump Rockville Pike, Rockville, Maryland http://www.regulations.gov under signed the Energy and Water, Legislative 20852, between 7:30 a.m. and 4:15 p.m. Docket ID NRC–2008–0421. The Federal Branch, and Military Construction and (Eastern Time) Federal workdays; rulemaking website allows you to Veterans Affairs Appropriations Act, telephone: 301–415–1677. receive alerts when changes or additions 2019 on September 21, 2018. That Act occur in a docket folder. To subscribe: appropriated approximately $911.0 For additional direction on obtaining (1) Navigate to the docket folder (NRC– million to the NRC, which is a decrease information and submitting comments, 2008–0421); (2) click the ‘‘Sign up for of approximately $11.0 million from FY see ‘‘Obtaining Information and Email Alerts’’ link; and (3) enter your 2018. Based on that total budget Submitting Comments’’ in the email address and select how frequently authority, the NRC is proposing to SUPPLEMENTARY INFORMATION section of you would like to receive emails (daily, collect $781.9 million in fees in FY this document. weekly, or monthly). 2019. FOR FURTHER INFORMATION CONTACT: Dated at Rockville, Maryland, this 28th day DATES: Submit comments by March 4, Michele Kaplan, Office of the Chief of January 2019. 2019. Comments received after this date Financial Officer, U.S. Nuclear For the Nuclear Regulatory Commission. will be considered if it is practical to do Regulatory Commission, Washington, Theresa V. Clark, so, but the NRC is able to ensure DC 20555–0001, telephone: 301–415– Deputy Director, Division of Rulemaking, consideration only for comments 5256; email: [email protected]. received before this date. Because Office of Nuclear Material Safety and SUPPLEMENTARY INFORMATION: Safeguards. OBRA–90 requires the NRC to collect [FR Doc. 2019–00435 Filed 1–30–19; 8:45 am] the FY 2019 fees by September 30, 2019, Table of Contents the NRC will not grant any requests for BILLING CODE 7590–01–P I. Obtaining Information and Submitting an extension of the comment period. Comments ADDRESSES: You may submit comments II. Background; Statutory Authority NUCLEAR REGULATORY by any of the following methods (unless III. Specific Request for Comment: Petition COMMISSION this document describes a different for Rulemaking method for submitting comments on a IV. Discussion 10 CFR Parts 170 and 171 specific subject): V. Regulatory Flexibility Certification • VI. Regulatory Analysis [NRC–2017–0032; Docket No. PRM–170–7; Federal Rulemaking Website: Go to NRC–2018–0172] http://www.regulations.gov and search VII. Backfitting and Issue Finality for Docket ID NRC–2017–0032. Address VIII. Plain Writing RIN 3150–AJ99 questions about NRC dockets to Carol IX. National Environmental Policy Act X. Paperwork Reduction Act Gallagher; telephone: 301–415–3463; Revision of Fee Schedules; Fee Public Protection Notification Recovery for Fiscal Year 2019 email: [email protected]. For XI. Voluntary Consensus Standards technical questions, contact the XII. Availability of Guidance AGENCY: Nuclear Regulatory individual listed in the FOR FURTHER XIII. Public Meeting Commission. INFORMATION CONTACT section of this XIV. Availability of Documents ACTION: Proposed rule. proposed rule. • Email comments to: I. Obtaining Information and SUMMARY: The U.S. Nuclear Regulatory [email protected]. If you Submitting Comments Commission (NRC) is proposing to do not receive an automatic email reply A. Obtaining Information amend the licensing, inspection, special confirming receipt, then contact us at project, and annual fees charged to its 301–415–1677. Please refer to Docket ID NRC–2017– applicants and licensees. These • Fax comments to: Secretary, U.S. 0032 when contacting the NRC about proposed amendments are necessary to Nuclear Regulatory Commission at 301– the availability of information for this implement the Omnibus Budget 415–1101. action. You may obtain publicly- Reconciliation Act of 1990, as amended • Mail comments to: Secretary, U.S. available information related to this (OBRA–90), which requires the NRC to Nuclear Regulatory Commission, action by any of the following methods: VerDate Sep<11>2014 17:23 Jan 30, 2019 Jkt 247001 PO 00000 Frm 00007 Fmt 4702 Sfmt 4702 E:\FR\FM\31JAP1.SGM 31JAP1 khammond on DSKBBV9HB2PROD with PROPOSALS Federal Register / Vol. 84, No. 21 / Thursday, January 31, 2019 / Proposed Rules 579 • Federal Rulemaking Website: Go to OBRA–90 (42 U.S.C. 2214). The IOAA methods listed in the ADDRESSES section http://www.regulations.gov and search generally authorizes and encourages of this document. for Docket ID NRC–2017–0032. Federal regulatory agencies to recover— The petitioner requests that the NRC • NRC’s Agencywide Documents to the fullest extent possible—costs amend its regulations to re-categorize Access and Management System attributable to services provided to WRT as a licensee that does not require (ADAMS): You may obtain publicly- identifiable recipients. The OBRA–90 full-cost recovery for fees billed to it available documents online in the requires the NRC to recover during the life of its license under 10 ADAMS Public Documents collection at approximately 90 percent of its budget CFR part 170. The petitioner also http://www.nrc.gov/reading-rm/ authority for the fiscal year through fees; requests that the NRC address adams.html. To begin the search, select in FY 2019, amounts appropriated for consistency issues between 10 CFR ‘‘Begin Web-based ADAMS Search.’’ For the development of regulatory parts 170 and 171 for small entities, and problems with ADAMS, please contact infrastructure for advanced reactor consider amending language under the NRC’s Public Document Room (PDR) technologies, international activities, § 170.11 to extend the time within reference staff at 1–800–397–4209 or Waste Incidental to Reprocessing, which a licensee may appeal the 301–415–4737, or by email to generic homeland security activities, assessment of fees and apply for a fee [email protected]. The ADAMS and Inspector General services for the exemption. The petitioner has asked the accession number for each document Defense Nuclear Facilities Safety Board NRC to consider these rule changes referenced in this document (if that are excluded from this fee-recovery within the context of its rulemaking to document is available in ADAMS) is requirement. The OBRA–90 first amend 10 CFR parts 170 and 171 to provided the first time that a document requires the NRC to use its IOAA collect FY 2019 fees. See the FY 2019 is referenced. For the convenience of the authority to collect service fees for NRC Policy Change section of this document reader, the ADAMS accession numbers work that provides specific benefits to for additional information. are also provided in a table in the identifiable applicants and licensees ‘‘Availability of Documents’’ section of (such as licensing work, inspections, IV. Discussion this document. and special projects). The regulations at FY 2019 Fee Collection—Overview • part 170 of title 10 of the Code of NRC’s PDR: You may examine and The NRC is issuing this FY 2019 Federal Regulations (10 CFR) authorize purchase copies of public documents at proposed fee rule based on the Energy these fees. But, because the NRC’s fee the NRC’s PDR, Room O1–F21, One and Water, Legislative Branch, and recovery under the IOAA (10 CFR part White Flint North, 11555 Rockville Military Construction and Veterans 170) does not equal 90 percent of the Pike, Rockville, Maryland 20852. Affairs Appropriations Act, 2019 (Pub. NRC’s budget authority for the fiscal L. 155–244) (enacted budget). The total B. Submitting Comments year, the NRC also assesses ‘‘annual enacted budget for the NRC in FY 2019 Please include Docket ID NRC–2017– fees’’ under 10 CFR part 171 to recover is approximately $911.0 million, a 0032 in the subject line of your the remaining amount necessary to meet decrease of approximately $11.0 million comment submission in order to ensure OBRA–90’s fee-recovery requirement. that the NRC is able to make your These annual fees recover costs that are from FY 2018. As explained previously, comment submission publicly available not otherwise collected through 10 CFR certain portions of the NRC’s total in this docket. part 170. budget are excluded from OBRA–90’s The NRC cautions you not to include fee-recovery requirement. Based on the identifying or contact information that III.
Recommended publications
  • PART I GENERAL PROVISIONS R12 64E-5.101 Definitions
    64E-5 Florida Administrative Code Index PART I GENERAL PROVISIONS R12 64E-5.101 Definitions ................................................................................................. I-1 64E-5.102 Exemptions ............................................................................................. I-23 64E-5.103 Records ................................................................................................... I-24 64E-5.104 Tests ... ................................................................................................... I-24 64E-5.105 Prohibited Use ........................................................................................ I-24 64E-5.106 Units of Exposure and Dose ................................................................... I-25 64E-5 Florida Administrative Code Index 64E-5 Florida Administrative Code Index PART II LICENSING OF RADIOACTIVE MATERIALS R2 64E-5.201 ...... Licensing of Radioactive Material .............................................................. II-1 64E-5.202 ...... Source Material - Exemptions .................................................................... II-2 R12 64E-5.203 ...... Radioactive Material Other than Source Material - Exemptions ................. II-4 SUBPART A LICENSE TYPES AND FEES R12 64E-5.204 ..... Types of Licenses ..................................................................................... II-13 SUBPART B GENERAL LICENSES 64E-5.205 ..... General Licenses - Source Material .........................................................
    [Show full text]
  • Nrc Regulatory Issue Summary 2005-23 Clarification of the Physical Presence Requirement During Gamma Stereotactic Radiosurgery Treatments
    UNITED STATES NUCLEAR REGULATORY COMMISSION OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS WASHINGTON, D.C. 20555 October 7, 2005 NRC REGULATORY ISSUE SUMMARY 2005-23 CLARIFICATION OF THE PHYSICAL PRESENCE REQUIREMENT DURING GAMMA STEREOTACTIC RADIOSURGERY TREATMENTS ADDRESSEES All gamma stereotactic radiosurgery (GSR) licensees. INTENT The U.S. Nuclear Regulatory Commission (NRC) is issuing this regulatory issue summary (RIS) to clarify the definition of the term “physically present,” as used in 10 CFR 35.615(f)(3). No specific action or written response is required. BACKGROUND In March 2005, during a licensing visit to a GSR facility, the NRC staff observed that the authorized medical physicist (AMP) did not remain physically present throughout one of the GSR treatments, as required by 10 CFR 35.615(f)(3). Instead, during the treatment, the AMP walked to the other end of the GSR suite and entered a treatment planning room located more than 30.5 meters (100 feet) away from the GSR treatment console. While discussing this incident with the licensee, the NRC staff recognized that the licensee was misinterpreting the physical presence requirement for GSR treatments. Based on the licensee’s interpretation of the regulations, the licensee considered any location within the GSR suite, including the treatment planning room, to be within hearing distance of normal voice from the GSR treatment console. The licensee believed that, within the contiguous boundary of its GSR suite, the human voice has sufficient volume, without electronic amplification, to alert the AMP of an emergency at essentially any location within its suite and the AMP could respond in a timely manner.
    [Show full text]
  • Radiosurgery Or Fractionated Stereotactic Radiotherapy Plus Whole-Brain Radioherapy in Brain Oligometastases: a Long-Term Analysis
    ANTICANCER RESEARCH 35: 3055-3060 (2015) Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis MARIO BALDUCCI1, ROSA AUTORINO1, SILVIA CHIESA1, GIANCARLO MATTIUCCI1, ANGELO POMPUCCI2, LUIGI AZARIO3, GIUSEPPE ROBERTO D’AGOSTINO1, MILENA FERRO1, ALBA FIORENTINO1, SERGIO FERSINO1, CIRO MAZZARELLA1, CESARE COLOSIMO4, VINCENZO FRASCINO1, CARMELO ANILE2 and VINCENZO VALENTINI1 Departments of 1Radiation Oncology, 2Neurosurgery, 3Physics and 4Radiology, Catholic University of the Sacred Heart, Rome, Italy Abstract. Aim: To analyze the outcome of patients with number, size, location, the patient’s Karnofsky performance brain oligometastases treated by radiosurgery (SRS) or status (KPS), age, extent of systematic disease and primary fractionated stereotactic radiotherapy (FSRT) after whole- disease status (4, 5). brain radiotherapy (WBRT). Patients and Methods: Overall Patients with one or two brain metastases and with survival (OS) and local control (LC) were evaluated in favorable prognostic features have a relatively favorable patients (patients) with 1-2 brain metastases. Results: Forty- survival; thus, the treatment is frequently more aggressive seven patients were selected. They were submitted to WBRT than for patients with multiple brain metastases (5). (median dose=3,750 cGy) followed by SRS (17 patients; Radiosurgery (SRS) delivered as a single fraction to median dose=1,500 cGy) or FSRT (30 patients; median individual intracranial lesions has been the most common dose=2,000 cGy). Median follow-up was 102 months technique used to dose-escalate on lesions following whole (range=17-151); the median survival was 22 months for the brain radiotherapy (WBRT) and considered as safe SRS group and 16 months for the FSRT group.
    [Show full text]
  • A Roadmap for Replacing High-Risk Radioactive Sources and Materials
    1 Permanent Risk Reduction: A Roadmap for Replacing High-Risk Radioactive Sources and Materials Miles A. Pomper James Martin Center for Nonproliferation Studies The National Academies of Sciences Radioactive Sources: Applications and Alternative Technologies Meeting January 31, 2020 2 Overview • CNS Workshops and Studies • Materials of Security Concern • Uses of Current High-Risk Materials ▫ Medicine ▫ Oil and gas industry • Strategy for Replacing High Activity Sources • Replacement Priority • Encouraging Replacement: Actions • Conclusions 3 CNS Workshops and Studies Since 2008, CNS has led a series of workshops and studies: . Alternatives to High-Risk Radiological Sources: The Case of Cesium Chloride in Blood Irradiation (2014) . Permanent Risk Reduction: A Roadmap for Replacing High-Risk Radioactive Sources and Materials (2015) . Treatment Not Terror: Strategies to Enhance External Beam Cancer Therapy in Developing Countries While Permanently Reducing the Risk of Radiological Terrorism (2016) . Additional material since: for NYC, NTI, and IAEA ICONS, draft language for 2016 NSS 4 Important Current Uses for High-Risk Materials, Existing Alternatives and Challenges, and Suggested Next Steps 5 High-Risk Sources • A task force report by the NRC listed 1. Americium-241 (Am-241) 2. Am-241/Beryllium (Be) 16 radionuclides as those of principal 3. Californium-252 (Cf-252) concern when considering the 4. Cesium-137 (Cs-137) problems they would cause if used in a 5. Cobalt-60 (Co-60) radiological dispersion device (RDD) 6. Curium-244 (Cm-244) • Considered an immediate danger only 7. Gadolinium-153 (Gd-153) when found in large enough amounts 8. Iridium-192 (Ir-192) to threaten life or cause severe 9.
    [Show full text]
  • Linac Based Radiosurgery and Stereotactic Radiotherapy
    Linac Based Radiosurgery and Stereotactic Radiotherapy Thomas Rockwell Mackie Professor Depts. Of Medical Physics, Human Oncology, and Engineering Physics University of Wisconsin Madison WI 53706 [email protected] Conflict of Interest Statement: I have financial interest in TomoTherapy Inc. Acknowledgements Peter Hoban, TomoTherapy Inc. Steve Goetsch, San Diego Gamma Knife Center Fang-Fang Yin, Duke University Chet Ramsey, Thompson Cancer Survival Center Karen Rosser, Royal Marsden Wolfgang Ullrich, BrainLab Inc. Outline Definition of SRS and SRT Stereo Market Indications for SRS/SRT History of Linac-Based SRS/SRT Variety of Systems QA for SRS Localization Imaging Small Field Dosimetry Stereotactic Radiosurgery Usually single fraction delivery » One large dose instead of ~30 fractions as in standard radiotherapy » Usually called SRS Also multiple fraction delivery » Often hypo-fractionated – Small number of fractions (e.g., 5) » Often called stereotactic radiotherapy (SRT) or fractionated stereotactic radiosurgery (FSRS) US Stereotactic Market Dedicated Machines US Stereotactic Market Dedicated Machines In 2003, 83 sites report plans to purchase in next few years 32 units in 2004 85% Linac based 15% Gamma Knife US Stereotactic Market Dedicated Machines Half of all dedicated SRS installations are in last 3 years (to 2003) US Stereotactic Market 100 80 60 40 cumulative number 20 Web Site Claims To 2005 0 1987 1989 1991 1993 1995 1997 GammaKnife CyberKnife 1999 Novalis 2001 2003 2004 2005 Brain Tumors Primary brain tumors » Tumors
    [Show full text]
  • A Framework for Quality Radiation Oncology Care
    Safety is No Accident A FRAMEWORK FOR QUALITY RADIATION ONCOLOGY CARE DEVELOPED AND SPONSORED BY Safety is No Accident A FRAMEWORK FOR QUALITY RADIATION ONCOLOGY CARE DEVELOPED AND SPONSORED BY: American Society for Radiation Oncology (ASTRO) ENDORSED BY: American Association of Medical Dosimetrists (AAMD) American Association of Physicists in Medicine (AAPM) American Board of Radiology (ABR) American Brachytherapy Society (ABS) American College of Radiology (ACR) American Radium Society (ARS) American Society of Radiologic Technologists (ASRT) Society of Chairmen of Academic Radiation Oncology Programs (SCAROP) Society for Radiation Oncology Administrators (SROA) T A R G E T I N G CAN CER CAR E The content in this publication is current as of the publication date. The information and opinions provided in the book are based on current and accessible evidence and consensus in the radiation oncology community. However, no such guide can be all-inclusive, and, especially given the evolving environment in which we practice, the recommendations and information provided in the book are subject to change and are intended to be updated over time. This book is made available to ASTRO and endorsing organization members and to the public for educational and informational purposes only. Any commercial use of this book or any content in this book without the prior written consent of ASTRO is strictly prohibited. The information in the book presents scientific, health and safety information and may, to some extent, reflect ASTRO’s and the endorsing organizations’ understanding of the consensus scientific or medical opinion. ASTRO and the endorsing organizations regard any consideration of the information in the book to be voluntary.
    [Show full text]
  • 1520.Full.Pdf
    ORIGINAL RESEARCH ADULT BRAIN Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among 11C-Methionine-PET, FDG-PET, MR Permeability Imaging, and MRI-ADC—Preliminary Results X N. Tomura, X M. Kokubun, X T. Saginoya, X Y. Mizuno, and X Y. Kikuchi ABSTRACT BACKGROUND AND PURPOSE: In patients with metastatic brain tumors after gamma knife radiosurgery, the superiority of PET using 11C-methionine for differentiating radiation necrosis and recurrent tumors has been accepted. To evaluate the feasibility of MR permea- bility imaging, it was compared with PET using 11C-methionine, FDG-PET, and DWI for differentiating radiation necrosis from recurrent tumors. MATERIALS AND METHODS: The study analyzed 18 lesions from 15 patients with metastatic brain tumors who underwent gamma knife radiosurgery. Ten lesions were identified as recurrent tumors by an operation. In MR permeability imaging, the transfer constant between intra- and extravascular extracellular spaces (/minute), extravascular extracellular space, the transfer constant from the extravascular extracellular space to plasma (/minute), the initial area under the signal intensity–time curve, contrast-enhancement ratio, bolus arrival time (seconds), maximum slope of increase (millimole/second), and fractional plasma volume were calculated. ADC was also acquired. On both PET using 11C-methionine and FDG-PET, the ratio of the maximum standard uptake value of the lesion divided by the maximum standard uptake value of the symmetric
    [Show full text]
  • 68Ga-DOTATOC PET/CT Follow up After Single Or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients
    brain sciences Article 68Ga-DOTATOC PET/CT Follow Up after Single or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients Fabio Barone 1,†, Francesco Inserra 1,†, Gianluca Scalia 2 , Massimo Ippolito 3, Sebastiano Cosentino 3 , Antonio Crea 4,5, Maria Gabriella Sabini 6,7, Lucia Valastro 6,7, Iolanda Valeria Patti 6,7, Stefania Mele 6,7, Grazia Acquaviva 8, Alessandra Tocco 8,9, Maria Tamburo 10, Francesca Graziano 2, Ottavio S. Tomasi 11,12, Rosario Maugeri 13, Gerardo Iacopino 13, Salvatore Cicero 4, Lidia Strigari 14 and Giuseppe Emmanuele Umana 4,* 1 Gamma-Knife Center, Department of Neurosurgery, Cannizzaro Hospital, 95126 Catania, Italy; [email protected] (F.B.); [email protected] (F.I.) 2 Neurosurgery Unit, Highly Specialized Hospital and of National Importance “Garibaldi”, 95122 Catania, Italy; [email protected] (G.S.); [email protected] (F.G.) 3 Department of Advanced Technologies, Nuclear Medicine and PET Cannizzaro Hospital, 95126 Catania, Italy; [email protected] (M.I.); [email protected] (S.C.) 4 Trauma Center, Gamma Knife Center, Department of Neurosurgery, Cannizzaro Hospital, 95126 Catania, Italy; [email protected] (A.C.); [email protected] (S.C.) 5 Neurosurgery Unit, Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy 6 Medical Physics Unit, Cannizzaro Hospital, 95126 Catania, Italy; [email protected] (M.G.S.); Citation: Barone, F.; Inserra, F.; [email protected] (L.V.); [email protected] (I.V.P.); [email protected] (S.M.) 7 Scalia, G.; Ippolito, M.; Cosentino, S.; INFN-Laboratori Nazionali del Sud, Via S. Sofia 62, 95123 Catania, Italy 8 UOC Radioterapia AOOE Cannizzaro di Catania, 95100 Catania, Italy; [email protected] (G.A.); Crea, A.; Sabini, M.G.; Valastro, L.; [email protected] (A.T.) Patti, I.V.; Mele, S.; et al.
    [Show full text]
  • A Very Effective Treatment for Symptomatic Cerebral Cavernomas PHAM CAM PHUONG 1, NGUYEN DUC LUAN 1, VO THI HUYEN TRANG 1, STEVEN E
    ANTICANCER RESEARCH 37 : 3729-3733 (2017) doi:10.21873/anticanres.11746 Radiosurgery with a Rotating Gamma System: A Very Effective Treatment for Symptomatic Cerebral Cavernomas PHAM CAM PHUONG 1, NGUYEN DUC LUAN 1, VO THI HUYEN TRANG 1, STEVEN E. SCHILD 2, DIRK RADES 3,4 and MAI TRONG KHOA 1,4 1The Nuclear Medicine and Oncology Center, Bach Mai Hospital, Hanoi, Vietnam; 2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.; 3Department of Radiation Oncology, University of Lübeck, Lübeck, Germany; 4Department of Nuclear Medicine, Ha Noi Medical University, Hanoi, Vietnam Abstract. Aim: To evaluate the value of radiosurgery with a At many centers, microsurgical resection is considered rotating gamma-system (RGS) for cerebral cavernomas. standard treatment approach for cerebral cavernomas (2). Patients and Methods: Seventy-nine patients with symptomatic Optimal clinical outcome requires complete resection of cerebral cavernomas underwent RGS radiosurgery at the Bach the cavernoma. Subtotal resection is associated with Mai Hospital, Hanoi, Vietnam. Median dose (single fraction) subsequent episodes of bleeding in approximately 40% of was 20 Gy (range=14-26 Gy). Endpoints included effect on cases (2). Therefore, only very experienced neurosurgeons headache, seizures and tumor size. Results: Of 60 patients with should perform resection of cerebral cavernomas. headache, 17% had complete response, 82% partial response Moreover, neurosurgical resection cannot be recommended and 2% stable disease (best response). Of 39 patients with for lesions in the brainstem or other eloquent areas of the seizures, 31% had complete response, 64% partial response brain, since it may result in significant morbidity. For and 5% stable disease.
    [Show full text]
  • Stereotactic Radiosurgery
    Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT) Stereotactic radiosurgery (SRS) is a non-surgical radiation therapy used to treat functional abnormalities and small tumors of the brain. It can deliver precisely-targeted radiation in fewer high-dose treatments than traditional therapy, which can help preserve healthy tissue. When SRS is used to treat body tumors, it's called stereotactic body radiotherapy (SBRT). SRS and SBRT are usually performed on an outpatient basis. Ask your doctor if you should plan to have someone drive you home afterward and whether you should refrain from eating or drinking or taking medication several hours before treatment. Tell your doctor if there's a possibility you are pregnant or if you're breastfeeding or if you're taking oral medication or insulin to control diabetes. Discuss whether you have an implanted medical device, claustrophobia or allergies to contrast materials. What is stereotactic radiosurgery and how is it used? Stereotactic radiosurgery (SRS) is a highly precise form of radiation therapy initially developed to treat small brain tumors and functional abnormalities of the brain. The principles of cranial SRS, namely high precision radiation where delivery is accurate to within one to two millimeters, are now being applied to the treatment of body tumors with a procedure known as stereotactic body radiotherapy (SBRT). Despite its name, SRS is a non-surgical procedure that delivers precisely-targeted radiation at much higher doses, in only a single or few treatments, as compared to traditional radiation therapy. This treatment is only possible due to the development of highly advanced radiation technologies that permit maximum dose delivery within the target while minimizing dose to the surrounding healthy tissue.
    [Show full text]
  • Medical Sources of Radiation
    Medical Sources of Radiation Professional Training Programs Oak Ridge Associated Universities Objectives To review the most common uses of radiation in medicine. To discuss new uses for radiation in medicine. To review pertinent regulatory issues. 2 Introduction Medical exposure to an average American is about 3 mSv/yrmSv/yr (300 mrem/yr),mrem/yr), or about 48% of the total average exposure of 620 mremmrem.. Medical exposure to radiation is the largest contributor to our annual average exposure from manman--mademade sources. 3 NCRP Report 160 4 Introduction People are intentionally and purposefully irradiated during medical radiological procedures, which is something that is usually avoided in all other applications using radiation. 5 Introduction The goal in medicine is to minimize risk (keep doses low), without compromising the benefit of the procedure (diagnosis or treatment). 6 Introduction Radiation dose to patients is not regulated. Radiation doses per procedure are decreasing (with a few exceptions), but more procedures are being performed. 7 Introduction There are traditionally three branches of medicine that use ionizing radiation. – Diagnostic Imaging – Nuclear medicine – Radiation therapy 8 Diagnostic Imaging Diagnostic X-X-RayRay Fluoroscopy Mammography Bone Densitometry Computed Tomography Special Procedures Cardiac Cath Lab 9 Diagnostic Imaging MRI and ultrasound procedures do not use ionizing radiation, so will not be discussed. 10 Diagnostic Imaging People who have had xx--rayray procedures or CT scans have been exposed to ionizing radiation, but are not radioactive. 11 Diagnostic Imaging The states regulate the users of x-x-rayray equipment, the FDA regulates the manufacture of x-x-rayray equipment. 12 Diagnostic Imaging 13 Diagnostic Imaging 14 Diagnostic Imaging 15 Diagnostic Imaging 16 Nuclear Medicine The patient is purposefully administered radioactive material, and becomes the source of radiation.
    [Show full text]
  • Stereotactic Radiosurgery
    Stereotactic Radiosurgery Clinical Coverage Criteria Overview The adjective “Stereotactic” describes a procedure during which a target lesion is localized relative to a fixed three dimensional reference system, such as a rigid head frame affixed to a patient, fixed bony landmarks, a system of implanted fiducial markers, or other similar system. This type of localization procedure allows physicians to perform image-guided procedures with a high degree of anatomic accuracy and precision. Stereotactic Radiosurgery (SRS) is a distinct discipline that utilizes externally generated ionizing radiation in certain cases to inactivate or eradicate a defined target(s) in the head or spine without the need to make an incision. The target is defined by high-resolution stereotactic imaging. To assure quality of patient care the procedure involves a multidisciplinary team consisting of a neurosurgeon, radiation oncologist, and medical physicist. SRS is typically performed in a single session (multiple fractions may be necessary when lesions are near critical structures), using a rigidly attached stereotactic guiding device, other immobilization technology and/or a stereotactic- guidance system, but can be performed in a limited number of sessions, up to a maximum of five. Technologies that are used to perform SRS include linear accelerators, particle beam accelerators, and multisource Cobalt 60 units. In order to enhance precision, various devices may incorporate robotics and real time imaging. Stereotactic body radiation therapy (SBRT) couples this anatomic accuracy and reproducibility with very high doses of highly precise, externally generated, ionizing radiation, thereby maximizing the ablative effect on the target(s) while minimizing collateral damage to adjacent tissues. SBRT is used to treat extra-cranial sites as opposed to SRS which is used to treat intra- cranial and spinal targets, and may be delivered in one to five sessions (fractions).
    [Show full text]